We have advised clients in the following industries:
Life Sciences
- Biotechnology
- Pharmaceuticals (Human and Veterinary)
- Nutritional Supplements
- Medical Devices
- Diagnostics
Chemicals & Industrial Materials
Food Processing
Manufacturing & Distribution
Machinery and Mechanical Devices
Financial Advisors & Investors (Institutional and Individual)
Below is a list of some of our clients. The list is representative only. We have not included all of our clients, each of whom is very important to us.
- BioMarker Strategies, LLC - A cancer diagnostics and medical device company developing a system for testing live tissue (tumor cells) to guide the use of targeted cancer therapeutics. BioMarker Strategies maintains its laboratory and office space in the Johns Hopkins Science and Technology Park in Baltimore, Maryland.
- Emergent BioSolutions, Inc. (NYSE: EBS) - A multinational biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and therapeutics. Emergent’s marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection.
- GARP Research & Securities Co. - An independent equity research firm for U.S. mid-cap and small-cap growth companies. Its recommendations are driven by an investment philosophy that focuses on long-term growth, quality and control of risk.
- HBK Capital Management - An alternative investment firm which manages a large global, multi-strategy hedge fund. Headquartered in Dallas, Texas, the firm also maintains U.S. offices in New York and Charlottesville, and foreign offices in London, Hong Kong and Tokyo.
- Three Dog Logistics - A logistics provider using complex proprietary technology and software to manage domestic and international shipments including drop shipping and commingling. Three Dog Logistics is the second fastest growing private company in Baltimore, Maryland (Baltimore Business Journal), and has expected annual revenue of $12 million in 2010.
Representative Clients and Client Industries